Prashant Nagre

Fermenta Biotech Limited exclusively licenses its proprietary enzymatic technology for manufacturing Molnupiravir to Aurigene Pharmaceutical Services Limited

Fermenta has signed a Definitive Agreement with Aurigene, a stepdown subsidiary of Dr Reddy's Laboratories Limited Mumbai, January 20, 2022:…

3 years ago

Prashant Nagre elevated to the position of Managing Director of Fermenta Biotech Limited

Strategic decision to fuel next phase of growth for the company New Delhi, May 11, 2021: Mr Krishna Datla, Promoter…

3 years ago

FBL pioneers the development of its patented enzymatic route of synthesis for Molunpiravir an investigational ‘orally active’ therapeutic alternative for COVID 19

This novel technology using green chemistry provides a sustainable, efficient and scalable form of treatment  to fight against COVID 19   New…

4 years ago

DIL Limited subsidiary, Fermenta Biotech Limited wins accolades at UBM India Pharma Awards 2018

~Fermenta Biotech Limited wins Awards for Excellence in Export Promotion, Pharma International Excellence and Excellence in Corporate Social Responsibility~ Mumbai,…

6 years ago